Table TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type [see all tables in this series...]

Part (iv) All clients with cannabis as primary drug: number of episodes reporting the stated drug as secondary

Country	Opioids	Cocaine	Other stimulants	Hypnotics/sedatives	Hallucinogens	Volatile substances	Cannabis	Alcohol	Others
Bulgaria	1	1	3	0	0	1	0	2	0
Czech Republic	13	2	97	1	21	11	0	35	4
Denmark	87	177	289	76	31	9	0	334	15
Germany	638	1564	3803	204	782	41	13517	3114	147
Ireland	13	187	243	42	13	14	1	346	2
Greece	57	93	62	35	48	11	5	14	10
Spain	111	1010	251	90	51	23	23	1544	48
France	497	442	305	93	81	22	0	1966	146
Italy	379	925	412	41	165	20	0	731	26
Cyprus	4	32	27	4	0	0	0	12	0
Latvia	1	0	4	6	0	1	0	7	0
Luxembourg	4	1	2	0	0	0	0	0	0
Malta	14	29	37	4	8	1	0	0	3
Netherlands	16	248	166	19	21	3	0	500	163
Austria	70	92	153	36	35	4	0	252	18
Slovakia	12	8	72	1	9	5	0	23	1
Finland	20	2	61	25	3	1	4	119	0
Sweden	40	20	186	102	24	2	0	135	17
United Kingdom	496	1827	2419	411	162	170	74	5553	102
Total	2473	6660	8592	1190	1454	339	13624	14687	702

Notes:

 Data on secondary drug use are only collected among all treatment clients and not separately for new treatment clients. 

 ‘Opioids’ include: heroin, methadone, other opioids; ‘Cocaine’ includes: cocaine HCl, crack cocaine; ‘Stimulants’ include: amphetamines, MDMA and derivates, other stimulants: ‘Cannabis’ can include herb or resin. For each client up to four secondary drugs can be reported. 

 A number of the clients report using the same drug both as primary and secondary drug, particularly for cannabis. Clients may report using different sub-types of the same substance, as defined in the TDI Protocol for the drugs categories. 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007.  

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)